Hanmi, Pharmaceutical Hanmi Pharmaceutical y Beijing Hanmi avanzan en los ensayos clínicos del BH3120 como inmunoterapia 07.08.2025 - 18:04:28 Hanmi Pharmaceutical Texas South Korea View original content:https://www.prnewswire.com/news-releases/hanmi-pharmaceutical-y-beijing-hanmi-avanzan-en-los-ensayos-clinicos-del-bh3120-como-inmunoterapia-302315346.html
